Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer

被引:84
作者
Deng, G
Peng, E
Gum, J
Terdiman, J
Sleisenger, M
Kim, YS
机构
[1] Univ Calif San Francisco, Gastrointestinal Res Lab, Vet Affairs Med Ctr 151M2, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA
关键词
colorectal cancer; hMLH1; DNA methylation; loss of heterozygosity;
D O I
10.1038/sj.bjc.6600148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microsatellite instability is present in over 80% of the hereditary non-polyposis colorectal carcinoma and about 15 - 20% of the sporadic cancer. Microsatellite instability is caused by the inactivation of the mismatch repair genes, such as primarily hMLH 1, hMSH2. To study the mechanisms of the inactivation of mismatch repair genes in colorectal cancers, especially the region-specific methylation of hMLH1 promoter and its correlation with gene expression, we analysed microsatellite instability, expression and methylation of hMLH1 and loss of heterozygosity at hMLH1 locus in these samples, Microsatellite instability was present in 17 of 71 primary tumours of colorectal cancer, including 14 of 39 (36% mucinous cancer and three of 32 (9%) non-mucinous cancer. Loss of hMLH1 and h/MSH2 expression was detected in nine and three of 16 microsatellite instability tumours respectively. Methylation at CpG sites in a proximal region of hMLH1 promoter was detected in seven of nine tumours that showed no hMLH1 expression, while no methylation was present in normal mucosa and tumours which express hMLH1. However, methylation in the distal region was observed in all tissues including normal mucosa and hMLH1 expressing tumours. This observation indicates that methylation of hMLH1 promoter plays an important role in microsatellite instability with a region-specific manner in colorectal cancer, Loss of heterozygosity at hMLH1 locus was present in four of 17 cell lines and 16 of 54 tumours with normal hMLH1 status, while loss of heterozygosity was absent in all nine cell lines and nine tumours with abnormal hMLH1 status (mutation or loss of expression), showing loss of heterozygosity is not frequently involved in the inactivation of hMLH1 gene in sporadic colorectal cancer. (C) 2002 Cancer Research UK.
引用
收藏
页码:574 / 579
页数:6
相关论文
共 50 条
  • [31] The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer
    Wang, Yibaina
    Li, Guangxiao
    Hu, Fulan
    Bi, Haoran
    Wu, Zhiwei
    Zhao, Xiaojuan
    Li, Ye
    Li, Shuying
    Li, Dandan
    Cui, Binbin
    Dong, Xinshu
    Zhao, Yashuang
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [32] The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer
    Yibaina Wang
    Guangxiao Li
    Fulan Hu
    Haoran Bi
    Zhiwei Wu
    Xiaojuan Zhao
    Ye Li
    Shuying Li
    Dandan Li
    Binbin Cui
    Xinshu Dong
    Yashuang Zhao
    Medical Oncology, 2014, 31
  • [33] Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients
    Somayeh Shahmoradi
    Ali Bidmeshkipour
    Ahmad Salamian
    Mohammad Hasan Emami
    Zahra Kazemi
    Mansoor Salehi
    Familial Cancer, 2012, 11 : 13 - 17
  • [34] Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients
    Shahmoradi, Somayeh
    Bidmeshkipour, Ali
    Salamian, Ahmad
    Emami, Mohammad Hasan
    Kazemi, Zahra
    Salehi, Mansoor
    FAMILIAL CANCER, 2012, 11 (01) : 13 - 17
  • [35] Colorectal cancer susceptibility associated with the hMLH1 V384D variant
    Ohsawa, Tomonori
    Sahara, Tomoko
    Muramatsu, Shino
    Nishimura, Yoji
    Yathuoka, Toshimasa
    Tanaka, Yoichi
    Yamaguchi, Kensei
    Ishida, Hideyuki
    Akagi, Kiwamu
    MOLECULAR MEDICINE REPORTS, 2009, 2 (06) : 887 - 891
  • [36] Undetectable expression of hMLH1 protein in sporadic colorectal cancer with replication error phenotype
    Koike, J
    Yamada, K
    Takano, S
    Kikuchi, Y
    Hemmi, H
    Koi, M
    Tsujita, K
    Yanagita, K
    Yoshio, T
    Shimatake, H
    DISEASES OF THE COLON & RECTUM, 1997, 40 (10) : S23 - S28
  • [37] DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer
    Wu, Fang
    Lu, Min
    Qu, Lu
    Li, Dai-Qiang
    Hu, Chun-Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5457 - 5463
  • [38] Poorly differentiated colorectal adenocarcinomas show higher rates of microsatellite instability and promoter methylation of p16 and hMLH1:: A study matched for T classification and tumor location
    Kazama, Yoshihiro
    Watanabe, Toshiaki
    Kanazawa, Takamitsu
    Tanaka, Junichiro
    Tanaka, Toshiaki
    Nagawa, Hirokazu
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (03) : 278 - 283
  • [39] Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma:: associations with clinicopathological features
    Shannon, BA
    Iacopetta, BJ
    CANCER LETTERS, 2001, 167 (01) : 91 - 97
  • [40] Evaluation of the Methylation Status of the MEIS1 Promoter Gene in Colorectal Cancer
    Soltani, Narjes
    Karimiani, Ehsan Ghayoor
    Farzanehfar, Mohammadreza
    Mashkani, Baratali
    Jafarian, Amirhossein
    Ashraf, Hami
    Rezyat, Arash Akhavan
    Soukhtanloo, Mohammad
    MIDDLE EAST JOURNAL OF CANCER, 2016, 7 (04) : 203 - 207